The challenge to further improvements in survival of patients with T-ALL: Current treatments and new insights from disease pathogenesis
Survival rates for children and adult patients with T-cell acute lymphoblastic leukemia (T-ALL) have improved during the past decade due to optimization of frontline multiagent chemotherapy regimens. The outcome for relapsed T-ALL after initial intensive chemotherapy is frequently fatal, however, be...
Saved in:
Published in | Seminars in hematology Vol. 57; no. 3; p. 149 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
01.07.2020
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!